| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.08B | $922.7M | $1.15B |
| YoY Revenue Growth % | +17.5% | -19.7% | — |
| Gross Profit | $415.0M | $324.2M | — |
| Gross Margin % | 38.3% | 35.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$15.6M | -$427.6M | -$223.7M |
| Operating Margin % | -1.4% | -46.3% | -19.5% |
| Net Income (GAAP) | -$45.7M | -$459.9M | -$268.9M |
| EBITDA (Normalized) | $9.8M | -$400.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $129.8M | $103.6M | -$43.0M |
| Capital Expenditures (CapEx) | $31.7M | $34.5M | — |
| Free Cash Flow (FCF) | $98.0M | $69.1M | -$43.0M |
| FCF Margin % | 9.0% | 7.5% | -3.7% |
| Return on Invested Capital (ROIC %) | -2.9% | -45.0% | — |
| Cash & Short-Term Equivalents | $95.7M | $76.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $519.2M | $549.9M | — |